News

A growing number of non-smoking women, many of them young, contract lung cancer every year and are often diagnosed with an advanced stage malignancy. This fall, NYP/Columbia opened the Women’s Lung and Health Center, one of only two programs in the nation to serve this under-recognized patient population.

As a new member of the PERT Consortium, inaugurated in 2015, NYP/Columbia is in the vanguard of treating pulmonary embolism with a rapid response, multidisciplinary team led by Philip Green, MD.

Researchers at NYP/Columbia have recently launched an important trial of immunotherapy plus chemotherapy as neoadjuvant therapy for patients with locally advanced non-small cell lung cancer (NSCLC).

Correction of chest wall anomalies, once avoided because of the scope of surgery, is now standard care

Update on ex vivo lung perfusion, a new method to assess and prepare donor lungs